Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$167.33
1.330.80%
At close: -
$167.33
0.000.00%
After Hours: Mar 28, 4:00 PM EDT
Comments
Loading...
Quest Diagnostics Analyst Ratings and Price Targets | NYSE:DGX | Benzinga
Quest Diagnostics Inc has a consensus price target of $165.67 based on the ratings of 21 analysts. The high is $191 issued by Baird on March 20, 2025. The low is $140 issued by Wells Fargo on February 3, 2023. The 3 most-recent analyst ratings were released by Baird, Citigroup, and JP Morgan on March 20, 2025, March 4, 2025, and February 4, 2025, respectively. With an average price target of $185.33 between Baird, Citigroup, and JP Morgan, there's an implied 10.76% upside for Quest Diagnostics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Baird
Citigroup
JP Morgan
Mizuho
UBS
1calculated from analyst ratings
Analyst Ratings for Quest Diagnostics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/20/2025 | Buy Now | 14.15% | Baird | Eric Coldwell79% | $190 → $191 | Maintains | Outperform | Get Alert |
| 03/04/2025 | Buy Now | 10.56% | Citigroup | Patrick Donnelly80% | $185 → $185 | Downgrade | Buy → Neutral | Get Alert |
| 02/04/2025 | Buy Now | 7.57% | JP Morgan | Lisa Gill59% | $173 → $180 | Maintains | Neutral | Get Alert |
| 02/03/2025 | Buy Now | 6.38% | Mizuho | Ann Hynes86% | $177 → $178 | Maintains | Outperform | Get Alert |
| 02/03/2025 | Buy Now | 1.6% | UBS | Kevin Caliendo71% | $166 → $170 | Maintains | Neutral | Get Alert |
| 02/03/2025 | Buy Now | 7.57% | Piper Sandler | David Westenberg60% | $165 → $180 | Reiterates | Neutral → Neutral | Get Alert |
| 01/31/2025 | Buy Now | 8.77% | Truist Securities | David Macdonald67% | $172 → $182 | Maintains | Hold | Get Alert |
| 01/31/2025 | Buy Now | 4.58% | Barclays | Stephanie Davis40% | $168 → $175 | Maintains | Equal-Weight | Get Alert |
| 01/06/2025 | Buy Now | 3.99% | Leerink Partners | Michael Cherny79% | $135 → $174 | Upgrade | Market Perform → Outperform | Get Alert |
| 12/17/2024 | Buy Now | 2.79% | Morgan Stanley | Erin Wright 66% | $145 → $172 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/13/2024 | Buy Now | 8.77% | B of A Securities | Derik De Bruin84% | $179 → $182 | Maintains | Buy | Get Alert |
| 12/10/2024 | Buy Now | 10.56% | Jefferies | Tycho Peterson82% | → $185 | Assumes | Buy → Buy | Get Alert |
| 10/28/2024 | Buy Now | -1.39% | Piper Sandler | David Westenberg60% | $150 → $165 | Maintains | Neutral | Get Alert |
| 10/24/2024 | Buy Now | 3.99% | Mizuho | Ann Hynes86% | $160 → $174 | Maintains | Outperform | Get Alert |
| 10/23/2024 | Buy Now | -0.79% | UBS | Kevin Caliendo71% | $165 → $166 | Maintains | Neutral | Get Alert |
| 10/23/2024 | Buy Now | 10.56% | Citigroup | Patrick Donnelly80% | $165 → $185 | Maintains | Buy | Get Alert |
| 10/23/2024 | Buy Now | 0.4% | Barclays | Stephanie Davis40% | $154 → $168 | Maintains | Equal-Weight | Get Alert |
| 10/23/2024 | Buy Now | 8.77% | Baird | Eric Coldwell79% | $157 → $182 | Upgrade | Neutral → Outperform | Get Alert |
| 10/07/2024 | Buy Now | -1.39% | Truist Securities | David Macdonald67% | $158 → $165 | Maintains | Hold | Get Alert |
| 08/28/2024 | Buy Now | -1.39% | Evercore ISI Group | Elizabeth Anderson47% | → $165 | Reinstates | → In-Line | Get Alert |
| 08/27/2024 | Buy Now | -7.97% | Barclays | Stephanie Davis40% | $144 → $154 | Maintains | Equal-Weight | Get Alert |
| 07/29/2024 | Buy Now | -10.36% | Piper Sandler | David Westenberg60% | $145 → $150 | Maintains | Neutral | Get Alert |
| 07/24/2024 | Buy Now | -7.97% | Baird | Eric Coldwell79% | $153 → $154 | Maintains | Neutral | Get Alert |
| 07/15/2024 | Buy Now | -5.58% | Truist Securities | David Macdonald67% | $150 → $158 | Maintains | Hold | Get Alert |
| 07/10/2024 | Buy Now | -1.39% | Citigroup | Patrick Donnelly80% | $145 → $165 | Upgrade | Neutral → Buy | Get Alert |
| 07/05/2024 | Buy Now | -8.56% | Baird | Eric Coldwell79% | $145 → $153 | Maintains | Neutral | Get Alert |
| 05/30/2024 | Buy Now | -7.37% | JP Morgan | Lisa Gill59% | $152 → $155 | Maintains | Neutral | Get Alert |
| 04/25/2024 | Buy Now | -13.94% | Barclays | Stephanie Davis40% | $138 → $144 | Maintains | Equal-Weight | Get Alert |
| 04/24/2024 | Buy Now | -13.34% | Citigroup | Patrick Donnelly80% | $135 → $145 | Maintains | Neutral | Get Alert |
| 04/24/2024 | Buy Now | -12.75% | UBS | Kevin Caliendo71% | $139 → $146 | Maintains | Neutral | Get Alert |
| 04/24/2024 | Buy Now | -10.36% | Truist Securities | David Macdonald67% | $145 → $150 | Maintains | Hold | Get Alert |
| 04/24/2024 | Buy Now | -7.37% | Mizuho | Ann Hynes86% | $150 → $155 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | -13.34% | Truist Securities | David Macdonald67% | → $145 | Reiterates | Hold → Hold | Get Alert |
| 02/26/2024 | Buy Now | -19.32% | Leerink Partners | Michael Cherny79% | → $135 | Initiates | → Market Perform | Get Alert |
| 02/07/2024 | Buy Now | -7.37% | Jefferies | Brian Tanquilut45% | $140 → $155 | Upgrade | Hold → Buy | Get Alert |
| 02/02/2024 | Buy Now | -13.34% | Truist Securities | David Macdonald67% | $150 → $145 | Maintains | Hold | Get Alert |
| 12/20/2023 | Buy Now | -10.36% | Truist Securities | David Macdonald67% | $145 → $150 | Maintains | Hold | Get Alert |
| 12/12/2023 | Buy Now | -4.38% | B of A Securities | Derik De Bruin84% | $140 → $160 | Upgrade | Neutral → Buy | Get Alert |
| 12/11/2023 | Buy Now | -13.34% | Citigroup | Patrick Donnelly80% | $130 → $145 | Maintains | Neutral | Get Alert |
| 12/07/2023 | Buy Now | -18.13% | UBS | Kevin Caliendo71% | $135 → $137 | Maintains | Neutral | Get Alert |
| 11/17/2023 | Buy Now | -10.95% | JP Morgan | John Stansel67% | $148 → $149 | Maintains | Neutral | Get Alert |
| 11/06/2023 | Buy Now | -16.33% | Piper Sandler | David Westenberg60% | $130 → $140 | Maintains | Neutral | Get Alert |
| 10/25/2023 | Buy Now | -22.31% | Citigroup | Patrick Donnelly80% | $142 → $130 | Maintains | Neutral | Get Alert |
| 10/16/2023 | Buy Now | -22.31% | Piper Sandler | David Westenberg60% | $145 → $130 | Maintains | Neutral | Get Alert |
| 08/03/2023 | Buy Now | -13.34% | Morgan Stanley | Ricky Goldwasser78% | $145 → $145 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/29/2023 | Buy Now | -13.34% | Piper Sandler | David Westenberg60% | → $145 | Initiates | → Neutral | Get Alert |
| 05/10/2023 | Buy Now | -13.34% | Morgan Stanley | Ricky Goldwasser78% | $158 → $145 | Maintains | Equal-Weight | Get Alert |
| 05/02/2023 | Buy Now | -11.55% | B of A Securities | Derik De Bruin84% | $166 → $148 | Downgrade | Buy → Neutral | Get Alert |
| 04/03/2023 | Buy Now | -15.14% | Citigroup | Patrick Donnelly80% | $125 → $142 | Upgrade | Sell → Neutral | Get Alert |
| 03/17/2023 | Buy Now | -4.38% | Truist Securities | David Macdonald67% | $170 → $160 | Maintains | Hold | Get Alert |
| 03/17/2023 | Buy Now | -1.39% | Mizuho | Ann Hynes86% | → $165 | Reiterates | → Buy | Get Alert |
| 02/03/2023 | Buy Now | -16.33% | Wells Fargo | Timothy Daley54% | $135 → $140 | Maintains | Equal-Weight | Get Alert |
| 01/25/2023 | Buy Now | -12.75% | Credit Suisse | Jonathan Yong64% | $143 → $146 | Maintains | Neutral | Get Alert |
| 01/23/2023 | Buy Now | -4.98% | Evercore ISI Group | Elizabeth Anderson47% | → $159 | Initiates | → In-Line | Get Alert |
| 01/12/2023 | Buy Now | -7.97% | Baird | Eric Coldwell79% | $143 → $154 | Maintains | Neutral | Get Alert |
| 01/06/2023 | Buy Now | -5.58% | Morgan Stanley | Ricky Goldwasser78% | $146 → $158 | Maintains | Equal-Weight | Get Alert |
| 12/14/2022 | Buy Now | -1.39% | Mizuho | Ann Hynes86% | $160 → $165 | Maintains | Buy | Get Alert |
| 11/17/2022 | Buy Now | -25.3% | Citigroup | Patrick Donnelly80% | $145 → $125 | Downgrade | Neutral → Sell | Get Alert |
| 10/21/2022 | Buy Now | -12.75% | Morgan Stanley | Ricky Goldwasser78% | $142 → $146 | Maintains | Equal-Weight | Get Alert |
| 10/21/2022 | Buy Now | -16.33% | Deutsche Bank | Pito Chickering67% | $129 → $140 | Maintains | Hold | Get Alert |
| 08/22/2022 | Buy Now | -15.14% | Morgan Stanley | Erin Wright75% | → $142 | Assumes | → Equal-Weight | Get Alert |
| 07/22/2022 | Buy Now | -4.38% | Mizuho | Ann Hynes86% | $185 → $160 | Maintains | Buy | Get Alert |
| 07/22/2022 | Buy Now | -14.54% | Credit Suisse | A.J. Rice68% | $158 → $143 | Maintains | Neutral | Get Alert |
| 05/03/2022 | Buy Now | -15.14% | Morgan Stanley | Ricky Goldwasser78% | $145 → $142 | Maintains | Equal-Weight | Get Alert |
| 04/25/2022 | Buy Now | -10.36% | Wells Fargo | Timothy Daley54% | $145 → $150 | Maintains | Equal-Weight | Get Alert |
| 04/22/2022 | Buy Now | -2.59% | B of A Securities | Derik De Bruin84% | $166 → $163 | Maintains | Buy | Get Alert |
| 04/04/2022 | Buy Now | — | Citigroup | Patrick Donnelly80% | — | Downgrade | Buy → Neutral | Get Alert |
FAQ
What is the target price for Quest Diagnostics (DGX) stock?
The latest price target for Quest Diagnostics (NYSE:DGX) was reported by Baird on March 20, 2025. The analyst firm set a price target for $191.00 expecting DGX to rise to within 12 months (a possible 14.15% upside). 32 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Quest Diagnostics (DGX)?
The latest analyst rating for Quest Diagnostics (NYSE:DGX) was provided by Baird, and Quest Diagnostics maintained their outperform rating.
When was the last upgrade for Quest Diagnostics (DGX)?
The last upgrade for Quest Diagnostics Inc happened on January 6, 2025 when Leerink Partners raised their price target to $174. Leerink Partners previously had a market perform for Quest Diagnostics Inc.
When was the last downgrade for Quest Diagnostics (DGX)?
The last downgrade for Quest Diagnostics Inc happened on March 4, 2025 when Citigroup changed their price target from $185 to $185 for Quest Diagnostics Inc.
When is the next analyst rating going to be posted or updated for Quest Diagnostics (DGX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Quest Diagnostics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Quest Diagnostics was filed on March 20, 2025 so you should expect the next rating to be made available sometime around March 20, 2026.
Is the Analyst Rating Quest Diagnostics (DGX) correct?
While ratings are subjective and will change, the latest Quest Diagnostics (DGX) rating was a maintained with a price target of $190.00 to $191.00. The current price Quest Diagnostics (DGX) is trading at is $167.33, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.